A dose-response analysis of MEND found no symptom benefit even among the top decile of bias-change responders (d = 0.11, ns)
[unresolved]
[no evidence]
[quiet]
[stable]
[undecided]
Among the 120 participants whose interpretation bias shifted by more than 1.5 SD, 12-month BDI-II change did not differ from controls. The absence of a responder subgroup argues against the interpretation that the null was driven by dilution from non-engagers.
Accurate
(+0)
Falsifiable
(+0)
Clear
(+0)
Novel
(+0)
Important
(+0)
▸ Score Details
Cited as evidence in 1 claim:
Randomized cognitive-bias modification targeting threat app…
(opposes)
cited by (1)
cited as opposes by:
[+0]
Randomized cognitive-bias modification targeting threat appraisal reduced appraisal bias by 0.62 SD but depression symptoms by only 0.08 SD at 12 months
clinical-psychology
randomized-trials
virtues: Accurate unrated · Falsifiable unrated · Clear unrated · Novel unrated · Important unrated
this claim:
A dose-response analysis of MEND found no symptom benefit even among the top decile of bias-change responders (d = 0.11, ns)
opposes (0)
no opposing evidence yet
Evidence Supporting (0)
No supporting evidence yet.
Evidence Against (0)
No opposing evidence yet.
Respondeo
Loading responses...
Log in to join the discussion.